LECONVIN
DEAD

Serial Number

87931502

Owner

Medoncare Pharmaceutical Co., Ltd.

Attorney

Timothy T. Wang

First Use Date

Jun 20, 2019

Filing Date

May 22, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LECONVIN Trademark

Serial Number: 87931502 • Registration: 5909234

LECONVIN is a trademark filed by Medoncare Pharmaceutical Co., Ltd. on May 22, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 32 (Light Beverages). The application is currently no longer active.

Owner Contact Info

Medoncare Pharmaceutical Co., Ltd. (7 trademarks)

Building 5, 229 Guyuan Road, Yuelu Dist.
Changsha, Hunan Prov. 410205 , CN

Entity Type: 99

Trademark Details

Filing Date

May 22, 2018

Registration Date

November 12, 2019

First Use Anywhere

June 20, 2019

First Use in Commerce

June 20, 2019

Published for Opposition

January 29, 2019

Cancellation Date

May 22, 2026

Goods & Services

Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, rhinitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemical-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctures in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes; Nutritional supplements; Dietetic foods, namely, dietetic crackers, dietetic sugar for medical use, Dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels

Beer; Water beverages; Non-alcoholic malt beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic water-based beverages; Aerated water; Non-alcoholic beverages flavored with tea; Vegetable drink; Preparations for making beverages, namely, fruit drinks; Syrups for beverages; Concentrates and powders used in the preparation of energy drinks and fruit-flavored beverages; Energy drinks; Energy drinks enhanced with vitamins, minerals, nutrients; Isotonic beverages; Isotonic drinks; Isotonic non-alcoholic drinks; Powders used in the preparation of isotonic sports drinks and sports beverages; Protein-enriched sports beverages; Sports drinks; Sports drinks enhanced with vitamins, minerals, nutrients; Sports drinks, namely, energy drinks; Sports drinks, namely, performance drinks; Whey beverages

Filing History

CANCELLED SEC. 8 (6-YR)
May 22, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 12, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 8, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 7, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 5, 2019 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 5, 2019 AITU
USE AMENDMENT FILED
Sep 17, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 17, 2019 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 29, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 29, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2018 CRFA
ASSIGNED TO LIE
Dec 21, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2018 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 17, 2018 GPRN
PRIORITY ACTION E-MAILED
Jul 17, 2018 GPRA
PRIORITY ACTION WRITTEN
Jul 17, 2018 CPRA
ASSIGNED TO EXAMINER
Jul 13, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 1, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2018 NWOS
NEW APPLICATION ENTERED
May 25, 2018 NWAP